The FDA last month approved Risperdal Consta (risperidone long-acting injection) for treating schizophrenia. It is the first long-acting, atypical antipsychotic the FDA has approved, reported Janssen Pharmaceutica, who is marketing the product.
Related Results
…
CAMBRIDGE, Mass. — Alkermes, Inc. (Nasdaq: ALKS) today announced that the Japanese organization of its partner Janssen-Cilag, Janssen Pharmaceutica K.K., submitted a new drug application to the Pharmaceuticals and Medical Devices Agency (PMDA) for marketing approval in Japan of RISPERDAL([R]) CONSTA([R]) [(risperidone) long-acting injection], an atypical antipsychotic medication for the treatment of schizophrenia. RISPERDAL CONSTA is the first and only long-acting, at…
TITUSVILLE, N.J., June 30 /PRNewswire-FirstCall/ — Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced that it has launched an authorized generic version of RISPERDAL(R) (risperidone) through Patriot Pharmaceuticals, L.L.C.
Patriot is a subsidiary of McNeil-PPC. …
LegalView.com would like to inform readers of its newly launched information portal dealing with the possibly unsafe prescription drugs Dostinex and Risperdal. Each of these information portals contains vital information for informing readers about the …
M2 PRESSWIRE-9 October 2006-US FDA: FDA approves the first drug to treat irritability associated with autism, Risperdal(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:06102006 The U.S. Food and Drug Administration (FDA) today approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.
Related Results
…
Johnson & Johnson of New Brunswicklast week won approval to market its blockbuster antipsychotic medication Risperdal to adolescents and pre teens.
The $4 billion drug has been OK’d by the U.S. Food and Drug Administration (FDA) to treat schizophrenia in adolescents ages 13 to 17 and as a short-term treatment for bipolar disorder in 10- to 17-year-olds. It i…
“Chemically, Risperdal is risperidone, which is an antipsychotic drug, with a chemical formula of C23H27FN4O2. Risperdal is generally used for treating schizophrenia and symptoms of manic depression. Risperdal changes the effects of the chemicals in the brain. This drug is also used in treating children with autism and…
CAMBRIDGE, Mass. — Alkermes, Inc. (Nasdaq: ALKS) today announced that the Company will expand production capacity for Risperdal(R) Consta(R) ((risperidone) long-acting injection), an atypical antipsychotic medication approved for the treatment of schizophrenia. This expansion at Alkermes’ Wilmington, Ohio, facility is de…
Business Editors and Health/Medical Writers
CAMBRIDGE, Mass.–(BW HealthWire)–Aug. 9, 2002
Alkermes, Inc. (Nasdaq:ALKS) today announced that its partner, Johnson and Johnson Pharmaceutical Research & Development (J&JPRD), has received approval from The Medicines Control Agency to market Risperdal Consta(TM) (risperidone) in the United Kingdom. The UK approval follows the recent approval of Risperdal Consta in Germany. The product will be l…
— Company Reports Strong Financial Performance with Record Net Income of $167 million for Fiscal 2008 –
— Company Expects Increased Revenues from RISPERDAL([R]) CONSTA([R]) and Positive Cash Flows from Operations in Fiscal 2009 –
CAMBRIDG…
